Real-world data analysis of perioperative chemotherapy patterns, G-CSF use, and FN status in patients with early breast cancer

ConclusionDespite the increasing use of escalated regimens in the last 5 –6 years, FNH continuously declined, and the odds of FNH were lower among patients treated with pegfilgrastim PP. These results may suggest the contribution of PP in part to suppressing FNH levels over the last 5–6 years.

http://link.springer.com/10.1007/s10549-023-07015-w

Source: Breast Cancer Research and Treatment - July 22, 2023 Category: Cancer & Oncology Source Type: research